机械与生物关节置换后的生存率:年龄的影响与手术死亡率得分对比
Jae Woong Choi1, Jeffrey Gaca2, Brittany A Zwischenberger2
1Division of Cardiothoracic Surgery, Department of Surgery, Duke University Medical Center, Durham NC; Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
The Annals of thoracic surgery
|February 16, 2026
概括
机械关置换 (MVR) 为70岁以下的患者提供生存益处,预计手术死亡率 (PROM) 风险低. 青老年患者使用生物假体的指导方针可能并不总是最佳的.
科学领域:
- 心血管外科心血管外科
- 生物医学工程 生物医学工程
- 临床结果研究研究
背景情况:
- 目前的指导方针经常建议65-70岁以上的患者使用生物假体门.
- 预测的手术死亡率 (PROM) 风险在接受米特拉置换 (MVR) 的患者中存在显著差异.
研究的目的:
- 为了比较生物和机械关假肢之间的生存结果.
- 分析患者年龄和PROM对不同门类型的生存优势的影响.
主要方法:
- 从1983年到2020年,对2092名接受隔离MVR的患者进行了分析.
- 考克斯的比例危险模型和逆倾向权重/倾向匹配被用来比较机械门和生物假体门之间的生存率.
- 生存优势被评估为年龄和PROM的函数.
主要成果:
- 观察到PROM与机械门的生存优势之间存在显著的相互作用 (P=0.004).
- 机械在患有低PROM的年轻患者中显示出更高的生存率 (例如,50岁的PROM<9%,63岁的PROM<5%,70岁的PROM<3%).
- 在任何年龄的PROM≥9%或在任何PROM水平的70岁以上患者中,对于机械门没有发现显著的生存益处.
结论:
- 机械MVR在患有低PROM的患者中提供了生存益处,高达70岁,挑战了一些当前的指南.
- 选择MVR的门应该是个性化的,考虑患者的年龄,PROM和其他临床因素.
- 生物假体门仍然是老年患者或那些手术风险较高的患者的考虑因素.
相关概念视频
Mitral Stenosis III: Medical Management
319
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
319
Mitral Valve Prolapse II: Assessment and Management
705
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
705
Mitral Regurgitation III: Medical Management
391
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
391
Mitral Stenosis IV: Nursing Management
300
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
300
Mitral Stenosis I: Introduction
800
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
800
Mitral Valve Prolapse III: Nursing Management
427
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
427


